Horizon Therapeutics (HZNP) Confirms Talks on Takeover With Three Large Pharma Cos.

November 29, 2022 4:26 PM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

The Board of Horizon Therapeutics plc (Nasdaq: HZNP) confirms that it is engaged in highly preliminary discussions with Amgen Inc. (NYSE: AMGN), Janssen Global Services, LLC (NYSE: JNJ) and Sanofi (NYSE: SNY) which may or may not lead to an offer being made for the entire share capital of the Company. There can be no certainty that any offer will be made for the Company.

In accordance with Rule 2.6 of the Irish Takeover Rules, each of the Possible Offerors is required, no later than 5:00 pm (New York time) on Jan. 10, 2023, to either (i) announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Irish Takeover Rules; or (ii) announce that it does not intend to make an offer for the Company, in which case the announcement will be treated as a statement to which Rule 2.8 of the Irish Takeover Rules applies. This deadline will only be extended with the consent of the Irish Takeover Panel in accordance with Rule 2.6(c) of the Irish Takeover Rules, at the request of the Company.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot M&A, Mergers and Acquisitions, Rumors

Related Entities

JPMorgan, Morgan Stanley, Definitive Agreement